Mizuho lowered the firm’s price target on Alexandria Real Estate to $145 from $180 and keeps a Buy rating on the shares. Risks exist, but life science lab landlord fears are overblown based on Mizuho’s cash runway analysis, the analyst tells investors in a research note. The firm’s analysis of cash runways of over 1,200 tenants suggests risks are smaller than perceived and manageable, the analyst tells investors in a research note.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ARE:
- Alexandria Real Estate Equities, Inc. Reports: 1Q23 Net Income per Share – Diluted of $0.44; and 1Q23 FFO per Share – Diluted, As Adjusted, of $2.19
- ARE Upcoming Earnings Report: What to Expect?
- Citi downgrades Healthpeak, likes Alexandria for life science exposure
- Alexandria Real Estate price target lowered to $144 from $155 at Evercore ISI
- Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.21 per Common Share for 1Q23, for an Aggregate of $4.78 per Common Share for the 12 Months Ending March 31, 2023, Up 24 Cents, or 5 Percent, Over the 12 Months Ended March 31, 2022
